IgG4-related autoimmune manifestations in Alemtuzumab-treated multiple sclerosis patients
Aigli G. Vakrakou1, Dimitrios Tzanetakos1, Maria-Eleptheria Evangelopoulos1, George E. Fragoulis2, Paraskevi Kazakou3, Eleni Lekka4, Nikolitsa Kafasi4, John S. Tzartos5,6, Elissavet Andreadou1, Georgios Koutsis1, Elias Gialafos1, Antonios Dimitrakopoulos1, Evanthia Zampeli7, Dimitra Rontogianni8, Stamatios Theocharis9, Evangelia Zapanti10, Panos-Alexis Stathopoulos1, Maria Anagnostouli1, Leonidas Stefanis1, Constantinos Kilidireas1
1Multiple Sclerosis & Demyelinating Diseases Unit, 1st Department of Neurology, School of Medicine, Eginition Hospital, National and Kapodistrian University of Athens, Greece
2Department of Propaedeutic Internal Medicine, Medical School, Rheumatology Unit, "Laiko" General Hospital, National and Kapodistrian University of Athens, Greece
3Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece
4Department of Immunology, Laiko General Hospital, 17 Agiou Thoma str, Athens 11527, Greece
5Second Department of Neurology, National and Kapodistrian University of Athens, School of Medicine, “Attikon” University Hospital, Rimini 1, Chaidari, 12462, Athens, Greece
6Tzartos NeuroDiagnostics, Neuroimmunology, Eslin street 3, 115 23 Athens, Greece
7Gastroenterology Department, "Alexandra" Hospital, Athens, Greece
8Pathology Department, “Evangelismos” General Hospital, Athens, Greece
9First Department of Pathology, Medical School, National and Kapodistrian University of Athens, Greece
10Department of Endocrinology, Alexandra Hospital, Athens, Greece
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Journal of Neuroimmunology
Tập 361
577759
Thông tin tác giả